Bioxytran, Inc
Pharmaceutical company · Needham, Massachusetts, United States · OTC: BIXT
Bioxytran, Inc is a pharmaceutical company headquartered in Needham, Massachusetts, United States. Its earliest recorded incorporation is in 2018. Its shares trade on OTC under the ticker BIXT. It has reported private securities offerings to the US SEC, most recently $130,000 sold in a notice filed in 2023.
Bioxytran at a glance
What does Bioxytran do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $130,000 sold (2023).
Frequently asked questions about Bioxytran
Where is Bioxytran headquartered?
Bioxytran, Inc is headquartered in Needham, Massachusetts, United States.
What does Bioxytran do?
Bioxytran, Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Bioxytran a public company?
Yes. Bioxytran, Inc trades on OTC under the ticker BIXT.
When was Bioxytran founded?
The earliest incorporation on record for Bioxytran, Inc is in 2018, according to public company registers.
Similar companies
- Verastem, Inc.Needham, Massachusetts, United States
- Chiasma, IncNeedham, Massachusetts, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences